TrialDrug design, development and therapy2026

Phase I Study Evaluating Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Recombinant Human Serum Albumin (rHSA) in Healthy Adults.

Veerendra Kumar Panuganti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.